Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXA-101 versus ceftazidime in complicated urinary tract infection including pyelonephritis
2009-011466-29Phase 2Completed
- Sponsor
- Calixa Therapeutics
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ceftolozane in complicated urinary tract infection (cUTI) and pyelonephritis (2 arms), sponsored by Calixa Therapeutics. Primary endpoint: Microbiological response at Test of Cure (per-subject, ME and mMITT populations). Started Apr 2009; status: completed.
02
Drugs
ceftolozane
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on 2009-011466-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011466-29.